Skip to main content
. 2022 Mar 20;2022:5229702. doi: 10.1155/2022/5229702

Table 4.

Pharmacological treatments for underlying cardiometabolic and psychological comorbidities in men with ED and men without ED.

Medications ED status Two-sided p value
ED (n = 5,185) No ED (n = 7,305)
Alpha blocker-heart conditions, n (%) 300 (5.8) 108 (1.5) <0.001
Antidepressants, n (%) 891 (17.2) 719 (9.8) <0.001
Blood pressure medication, n (%) 1,677 (32.3) 1,034 (14.2) <0.001
Statins, n (%) 1,479 (28.5) 845 (11.6) <0.001
Diabetes medication, n (%) 712 (13.7) 355 (4.9) <0.001
Nitrates, n (%) 170 (3.3) 46 (0.6) <0.001
Vasodilators, n (%) 114 (2.2) 28 (0.4) <0.001
≥1 of the above, n (%) 2,836 (54.7) 2,047 (28.0) <0.001

ED, erectile dysfunction.